Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04030005 AT-Resolvin D1 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA13010061 1-hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone 1-hydroxy-2-(beta-D-glucopyranosyloxy)-9,10-anthraquinone C20H18O9 402.095085
LMFA03110229 8-epi-5-D2c-IsoP (S,E)-5-hydroxy-7-((1S,2S,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA08020259 N-(14Z-tricosenoyl) taurine N-(14Z-tricosenoyl) taurine NAT 23:1 C25H49NO4S 459.338230
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496
LMFA03110171 5-epi-5-E2c-IsoP (R,E)-5-hydroxy-7-((1R,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA03110126 15-E2c-IsoP 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S] FA 20:4;O3 C20H32O5 352.224976
LMFA02040127 (9S,12S,16R)-d14-10-PhytoF[10S,13R] (S)-9-hydroxy-9-((2S,4S,5R)-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)nonanoic acid FA 18:2;O4 C18H32O6 344.219891
LMFA03020072 Delta(6)-trans,Delta(8)-cis-leukotriene B4 (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020072 Delta(6)-trans,Delta(8)-cis-leukotriene B4 (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020072 Delta(6)-trans,Delta(8)-cis-leukotriene B4 (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA05000715 avocadene acetate 2S,4S-dihydroxy-16E-heptadecen-1-yl-acetate FOH 19:2;O3 C19H36O4 328.261361
LMFA01031049 12Z,15Z,18Z-Tetracosatrienoic acid 12Z,15Z,18Z-Tetracosatrienoic acid FA 24:3 C24H42O2 362.318481
LMFA03110156 8,11-diepi-8-F2c-IsoP 8R,12S,14R-trihydroxy-5Z,9E-prostadienoic acid-cyclo[11S,15S] FA 20:3;O3 C20H34O5 354.240626
LMFA03110160 ent-5-epi-12-F2t-IsoP 6R,8S,12R-trihydroxy-10E,14Z-prostadienoic acid-cyclo[5S,9S] FA 20:3;O3 C20H34O5 354.240626
LMFA03110240 5,12-diepi-12-D2t-IsoP 4-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA07030018 Type III cyanolipid 18:3 ester (3-cyano-2-methylprop-2E-en-1-yl) 9Z,12Z,15Z-octadecatrienoate C23H35NO2 357.266779
LMFA07030018 Type III cyanolipid 18:3 ester (3-cyano-2-methylprop-2E-en-1-yl) 9Z,12Z,15Z-octadecatrienoate C23H35NO2 357.266779
LMFA07030018 Type III cyanolipid 18:3 ester (3-cyano-2-methylprop-2E-en-1-yl) 9Z,12Z,15Z-octadecatrienoate C23H35NO2 357.266779
LMFA07070046 4,8 dimethylnonanoyl carnitine 3-[(4,8-dimethylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 11:0 C18H35NO4 329.256609
LMFA07070046 4,8 dimethylnonanoyl carnitine 3-[(4,8-dimethylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 11:0 C18H35NO4 329.256609
LMFA01050451 (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid (Z,7R,8S)-7,8-dihydroxyoctadec-9-enoic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01050451 (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid (Z,7R,8S)-7,8-dihydroxyoctadec-9-enoic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01050451 (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid (Z,7R,8S)-7,8-dihydroxyoctadec-9-enoic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01050514 Hypusine (2S)-2-amino-6-{[(2S)-4-amino-2-hydroxybutyl]amino}hexanoic acid C10H23N3O3 233.173941
LMFA01050514 Hypusine (2S)-2-amino-6-{[(2S)-4-amino-2-hydroxybutyl]amino}hexanoic acid C10H23N3O3 233.173941
LMFA13010057 (3S,5R,6S,7E,9x)-7-Megastigmene-3,6,9-triol 9-glucoside 2-{[(3E)-4-(1,4-dihydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol C19H34O8 390.225371
LMFA05000557 (9Z,12Z)-octadecadien-1-ol (9Z,12Z)-octadeca-9,12-dien-1-ol FOH 18:2 C18H34O 266.260966
LMFA01030949 (E)-10-Oxo-8-decenoic acid (8E)-10-oxodec-8-enoic acid FA 10:2;O C10H16O3 184.109945
LMFA05000551 (2S)-octan-2-ol (2S)-octan-2-ol FOH 8:0 C8H18O 130.135765
LMFA05000621 2-Undecanol undecan-2-ol FOH 11:0 C11H24O 172.182715
LMFA02030021 16-F1c-PhytoP 8-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)octanoic acid FA 18:2;O3 C18H32O5 328.224976
LMFA02030018 ent-9-epi-9-F1c-PhytoP (S,E)-11-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-9-hydroxyundec-10-enoic acid FA 18:2;O3 C18H32O5 328.224976
LMFA04020099 (10S,13R,17R)-d15-11-NeuroF[11S,14R] (S,4Z,7Z)-10-hydroxy-10-((2S,4R,5R)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid FA 22:5;O4 C22H34O6 394.235541
LMFA02030045 9-E1c-PhytoP (S,E)-11-((1R,2S,3R)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-9-hydroxyundec-10-enoic acid FA 18:3;O3 C18H30O5 326.209326
LMFA03110276 ent-8-epi-5-J2-IsoP (R,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid FA 20:5;O2 C20H30O4 334.214411
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA03110337 ent-10,17-diepi-17-F2c-dihomo-IsoP 1a,1b-dihomo-11R,13S,17S-trihydroxy-7Z,15E-prostadienoic acid-cyclo[10R,14R] FA 22:3;O3 C22H38O5 382.271926